**Tukaram Mundhe**, Maharashtra Food and Drug Administration (FDA) Commissioner, has stated that adjudication proceedings against **Ajay Devgn** in the Vimal pan masala controversy will continue unabated. This decision comes despite the actor’s legal challenge, as per a report by TOI.
**Key Highlights**:
- Proceedings against **Ajay Devgn** will continue as per the law.
- **Tukaram Mundhe** has asserted the FDA’s stance on the matter.
- **Vimal pan masala** controversy remains a priority for the Maharashtra FDA.
Context: Maharashtra FDA Stands Firm
**Tukaram Mundhe** emphasized that the Maharashtra FDA is committed to upholding the law, regardless of any legal challenges. The FDA Commissioner’s statement underscores the department’s resolve to address the Vimal pan masala controversy.
Response: FDA’s Commitment to the Law
According to reports, **Tukaram Mundhe** has assured that the FDA will proceed in accordance with the law. This stance is likely to be met with scrutiny, as the controversy surrounding **Ajay Devgn**’s advertisement continues to unfold.
As the Maharashtra FDA remains committed to its stance, the next steps in this controversy will be crucial in determining the outcome. The FDA’s resolve to uphold the law is a testament to its dedication to protecting consumer interests in the state.